Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

ICS use is common in bronchiectasis, including in those not currently recommended ICS according to bronchiectasis guidelines. ICS use may be associated with reduced exacerbation frequency in patients with elevated blood eosinophils.

Authors

Institutions

Publication Details

Journal
Thorax
Published
2025-03-23
DOI
https://doi.org/10.1136/thorax-2024-221825
Citations
16
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
24.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Adam T. Hill, Jennifer S. Pollock, Sabina Skgrat, Francesco Blasi et al.
16 citations
Thorax
Cystic Fibrosis Research Advances
24.29
article

Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Adam T. Hill, Jennifer S. Pollock, Sabina Skgrat, Francesco Blasi, Josje Altenburg, Michal Shteinberg, Menno M. van der Eerden, Robert C. Wilson, Oriol Sibila, Michael R. Loebinger, Charles Haworth, J.S. Elborn, Letizia Traversi, Felix C. Ringshausen, Raja Dhar, Eva Polverino, Katerina Dimakou, Rosario Menéndez, Paula Kauppi, Pieter Goeminne, Apostolos Bossios, Muhammad Irfan, James Duncan Chalmers, Venera Eshenkulova, Natalie Lorent, Tobias Welte, Melissa J. McDonnell, Montserrat Vendrell, Branislava Milenković, Anthony De Soyza, Pontus Mertsch, Adelina Amorim, Dušanka Obradović, Eva Van Braeckel, Pierre‐Régis Burgel, Stefano Aliberti, Adam Nowinski, Sermin Borecki, Antoní Torres, Megan Crichton, Marlène Murris, Wim Boersma, Luis Máiz‐Carro
article en
16 citations

Abstract

ICS use is common in bronchiectasis, including in those not currently recommended ICS according to bronchiectasis guidelines. ICS use may be associated with reduced exacerbation frequency in patients with elevated blood eosinophils.

ThoraxVol. 80(6)
Aga Khan University (PK), Queen's University Belfast (GB), Karolinska University Hospital (SE), Humanitas University (IT), University of Ulster (GB), University of Ljubljana (SI), Technion – Israel Institute of Technology (IL), University of Dundee (GB), Universidade do Porto (PT), University of Milan (IT), Universidad de Alcalá (ES), Universitat de Girona (ES), Royal Papworth Hospital (GB), Universitair Ziekenhuis Leuven (BE), Ghent University Hospital (BE), Erasmus MC (NL), University Hospital Galway (IE), Edinburgh Royal Infirmary (GB), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Hospital de São João (PT), LMU Klinikum (DE), Hospital Universitari i Politècnic La Fe (ES), Centre Hospitalier Universitaire de Toulouse (FR), Fatih University (TR), Ghent University (BE), Medizinische Hochschule Hannover (DE), Sujata Birla Hospital and Medical Research Center (IN), Hôpital Cochin (FR), Royal Brompton Hospital (GB), Northwest Hospital (US), Centre for Biomedical Network Research on Rare Diseases (ES), Univerzitetski Klinički Centar Srbije (RS), Carmel Medical Center (IL), Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE), Vall d'Hebron Hospital Universitari (ES), Royal Victoria Hospital (GB), Humanitas University in Sosnowiec (PL), Museo Nacional de Sanidad (ES), Allergy and Asthma Federation (FI), National Center of Cardiology and Internal Medicine (KG), Institute for Pulmonary Diseases of Vojvodina (RS), Hospital Universitario Ramón y Cajal (ES), IRCCS Humanitas Research Hospital (IT), Sotiria General Hospital (GR), Imperial College London (GB), Istanbul University (TR), Universitat de Barcelona (ES), Ludwig-Maximilians-Universität München (DE), Newcastle University (GB), Erasmus University Rotterdam (NL)
AstraZeneca, GlaxoSmithKline, CSL Behring, European Respiratory Society, LifeArc, European Federation of Pharmaceutical Industries and Associations, Insmed, European Commission, Innovative Medicines Initiative, Grifols, Horizon 2020 Framework Programme
Good health and well-being
Openalex Percentile: Top 0%
Cystic Fibrosis Research Advances
24.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.